Lansoprazole Capsule, Delayed Release
Product Images NDC 82461-713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 82461-713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medcore Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole-figure-1 (Lansoprazole Figure 1)

FDA Label Image

Lansoprazole-figure-2 (Lansoprazole Figure 2)

FDA Label Image

Lansoprazole-str (Lansoprazole Str)

FDA Label Image

Lansoprazole-30mg-30s-b (Lansoprazole 30mg 30s B)

Lansoprazole-30mg-30s-b (Lansoprazole 30mg 30s B)
This text provides information about a medication in the form of ink and black capsules containing 30mg of Lansoprazole, USP as enteric-coated granules. Each capsule is imprinted with *263 for identification purposes. The usual dosage instructions are not provided, and it advises not to accept if the seal over the bottle opening is broken or missing. The storage temperature is recommended to be between 20° to 25°C (68°to 77°F), and it should be kept in a tight container as per USP standards. The medication should be kept out of the reach of children. The text also includes details about the manufacturer, distributor, and contact information for inquiries.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.